sulfasalazine has been researched along with Leukocytosis in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Leukocytosis: A transient increase in the number of leukocytes in a body fluid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Agranulocytosis is a rare but serious adverse effect of sulfasalazine treatment." | 7.81 | Hyperleucocytosis following G-CSF treatment for sulfasalazine-induced agranulocytosis. ( Chan, K; Farooq, R, 2015) |
| "Agranulocytosis is a rare but serious adverse effect of sulfasalazine treatment." | 3.81 | Hyperleucocytosis following G-CSF treatment for sulfasalazine-induced agranulocytosis. ( Chan, K; Farooq, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, K | 1 |
| Farooq, R | 1 |
| Nishiya, K | 1 |
| Tanaka, Y | 1 |
2 other studies available for sulfasalazine and Leukocytosis
| Article | Year |
|---|---|
Hyperleucocytosis following G-CSF treatment for sulfasalazine-induced agranulocytosis.
Topics: Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Female; Filgrastim; Granulocyte | 2015 |
Co-existence of non-Hodgkin's lymphoma in the leukemic phase and polyarthritis simulating rheumatoid arthritis.
Topics: Anti-Infective Agents; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Humans; Leukocytos | 1997 |